title: Intrathecal analgesia: time to consider it for your patient?
abstract: When systemic analgesics or antispasmodics fail to control chronic pain or cause intolerable adverse effects, an intrathecal drug delivery system may be the best bet.
authors: Department of Anesthesiology and Pain Management, Department of Family and Social Medicine/Palliative Medicine, Montefiore Medical Center, Bronx, NY, USA. Email: jtsukano@montefiore.org.
authors: Naum
authors: N
authors: Shaparin
authors: Andrew
authors: A
authors: Sim
authors: Marco
authors: M
authors: Pappagallo
authors: Karina
authors: K
authors: Gritsenko
authors: Veronica
authors: V
authors: Carullo
authors: Jessica
authors: J
authors: Tsukanov
authors: Boleslav
authors: B
authors: Kosharskyy
mesh_terms: D000698:Analgesia / Q000009:adverse effects / Q000379:methods; D000700:Analgesics / Q000008:administration & dosage*; D059350:Chronic Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004361:Drug Tolerance; D006801:Humans; D015918:Infusion Pumps, Implantable; D060186:Infusions, Spinal / Q000009:adverse effects / Q000379:methods; D059408:Pain Management / Q000379:methods; D010147:Pain Measurement; D010276:Parasympatholytics / Q000008:administration & dosage*; D018579:Patient Selection; D016896:Treatment Outcome
chemical_list: D000700:Analgesics; D010276:Parasympatholytics